Key result
Intracoronary nicardipine achieved complete restoration of TIMI 3 flow in 98.6% of patients with coronary artery disease and increased coronary blood flow.
Why the study?
The review aimed to assess the efficacy of intracoronary nicardipine in treating no reflow among CAD patients undergoing revascularization.
Does intracoronary nicardipine improve therapeutic and safety outcomes in adult patients with CAD experiencing no reflow during revascularization?
Systematic Review
Does intracoronary nicardipine improve therapeutic and safety outcomes in adult patients with CAD experiencing no reflow during revascularization?
Intracoronary nicardipine effectively restores TIMI 3 flow and increases coronary blood flow in CAD patients experiencing no-reflow during revascularization.
Answers are grounded in this paper and cite their sources.
Supports IC nicardipine for no-reflow during revascularization; extends evidence for TIMI 3 restoration and CBF improvement.
Aim: This systematic review aimed to shed light on the efficacy of intracoronary (IC) nicardipine in treating no reflow with CAD undergoing revascularization. Methods: Literature search was performed on databases with following eligibility criteria: adult patients with CAD; clinical trials or observational studies; IC nicardipine as intervention; therapeutic and safety outcome reported. Results: A total of 1249 papers were yielded during the literature search. Of these, 11 studies were finalized for this systematic review. Complete restoration of TIMI 3 flow was observed in 98.6% of the patients receiving IC nicardipine. A significant increase in the CBF after infusion of IC nicardipine (p < 0.05) was also observed. Conclusion: IC nicardipine significantly increases CBF and decreases coronary vascular resistance.
No takes yet. Share an insight, caveat, or question.
Rehan et al. (2023) conducted a systematic review in Coronary Artery Disease (CAD) with no reflow. Intracoronary nicardipine was evaluated on Complete restoration of TIMI 3 flow and coronary blood flow (CBF) (p=< 0.05). Intracoronary nicardipine achieved complete restoration of TIMI 3 flow in 98.6% of patients with coronary artery disease and increased coronary blood flow.
Synapse has enriched 10 related papers. Consider them for comparative context: